Vitamin D insufficiency could play a role in the development of Parkinson's disease
Researchers at Emory University report in the March, 2011 issue of Archives of Neurology the finding of a correlation between insufficient levels of vitamin D and the development of early Parkinson's disease (PD).
In the article's background information, Marian L. Evatt, MD, MS of Emory University School of Medicine and the Atlanta Veterans Affairs Medical Center and colleagues remark that "Vitamin D insufficiency has been reported to be more common in patients with Parkinson's disease than in healthy control subjects, but it is not clear whether having a chronic disease causing reduced mobility contributes to this relatively high prevalence."
The study included 157 placebo recipients who participated in The Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) trial of men and women with early, untreated Parkinson's disease. Blood samples obtained upon enrollment and at the final visit after 13 months were analyzed for levels of 25-hydroxyvitamin D.
A high percentage of subjects had vitamin D insufficiency or deficiency at both points of the study. While 69.4 percent had vitamin D insufficiency defined as levels of less than 30 nanograms per milliliter (ng/mL) at the beginning of the study, 26.1 percent were classified as deficient with levels of less than 20 ng/mL. The prevalence of insufficiency at the final visit was 51.6 percent, and deficiency occurred in 7 percent.
"Previous studies in Asian populations reported a higher prevalence of hypovitaminosis D (deficiency or insufficiency) in patients with more advanced disease, suggesting that long-term effects of Parkinson's disease may contribute to the development of insufficient vitamin D concentrations," the authors write. "Contrary to our expectation that vitamin D levels might decrease over time because of disease-related inactivity and reduced sun exposure, vitamin D levels increased over the study period. These findings are consistent with the possibility that long-term insufficiency is present before the clinical manifestations of Parkinson's disease and may play a role in the pathogenesis of PD."
"To our knowledge, the study cohort is the largest and most well-characterized cohort of patients with PD in whom vitamin D status has been investigated," they observe. "We confirm a high prevalence of vitamin D insufficiency in patients with recent onset of PD, during the early clinical stages in which patients do not require symptomatic therapy."
Parkinson’s disease (and parkinsonism) presents a challenge for both the conventional physician and the alternative medicine physician. You should not try to manage Parkinson’s disease on your own; always consult a physician if you have symptoms of Parkinson’s disease. The Life Extension Foundation recommends the following supplements, which may help postpone the initiation of levodopa therapy, for patients who are in the disease’s early stages:
CoQ10—1200 to 2400 milligrams (mg)/day
ALC—1000 to 2000 mg/day
Vitamin E—400 to 800 international units (IU)/day of alpha-tocopherol with at least 200 mg/day of gamma-tocopherol
Vitamin C—1000 to 5000 mg/day
Grape seed extract—100 to 300 mg/day
Ginkgo biloba—120 mg/day
Green tea extract—at least 725 mg/day (93 percent or higher in polyphenols)
Glutathione—250 to 500 mg/day
Cysteine—500 to 1200 mg/day
Selenium—200 micrograms (mcg)/day
Lipoic acid—150 to 600 mg/day
Aged garlic extract—600 to 1200 mg/day
Melatonin—3 mcg/day to 10 mg/day (taken at night)
Tyrosine—500 to 1000 mg/day
Phenylalanine—500 to 1000 mg/day
NADH—5 to 10 mg/day
B complex—at least 50 mg/day of riboflavin, 75 mg/day of vitamin B6, and 8700 mcg/day of folic acid
DHEA—25 to 50 mg/day (increase dose according to blood test results)
PS—100 to 300 mg/day
Fish oil—at least 700 to 1400 mg/day of EPA and 500 to 1000 mg/day of DHA
In addition, strong coffee upon waking has been shown to reduce symptoms. A number of prescription drugs, including MAO inhibitors and dopamine agonists, may also be used as monotherapy early in the disease to postpone levodopa therapy. Because of the risk of adverse effects, patients who have Parkinson’s disease, or people who suspect that they may have Parkinson’s disease, should work closely with a physician to determine their optimal dosages of these supplements. Finally, it’s important to maintain a “clean” diet and get regular, moderate exercise.
If you find you don’t sleep well with melatonin—or are already taking one of Life Extension®’s stand-alone melatonin formulas at a different dose that works for you—Life Extension offers Enhanced Natural Sleep® without Melatonin.
The consequences of sleep deprivation go far beyond the miseries of fatigue and diminished performance. Decades of clinical research document that a good night’s rest supports nearly all systems of the body, including:
Skin health and youthful appearance
Healthy collagen formation
Insulin levels already within normal range
Healthy body weight
Glucose levels already within normal range
Blood pressure already within normal range
Healthy cell division
Comprehensive Nutrient Packs
Are you always in a last-minute rush to pack your supplements before you travel? Or maybe you'd like some help keeping track of the supplements you take. Wouldn't life be easier if your most important supplements were already organized into convenient daily packs? Comprehensive Nutrient Packs will help simplify your supplement routine. Even on days when you are running late for the office, just grab a pack to take with you. No need to ever miss your daily supplementation again.
The Comprehensive Nutrient Packs provide the following formulations at no extra cost compared with purchasing each product separately:
Two-Per-Day Multinutrient Tablets
Triple-Action Cruciferous Vegetable Extract with Resveratrol
Super Ubiquinol CoQ10 with Enhanced Mitochondrial Support™
Super Omega-3 EPA/DHA with Sesame Lignans & Olive Fruit Extract